New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilisers, is preparing a database for monitoring the prices of all the drugs and medical devices that might be overcharged by hospitals and companies.
Apart from stents, the prices of all the notified medical devices, considered as drugs under the Drugs and Cosmetics Act, will now be monitored, such as disposable hypodermic syringes and needles, disposable perfusion sets, devices of HIV, HBsAg and HCV, catheters, intra-ocular lenses, cannulae, heart valves, scalp vein set, and internal prosthetic replacements.
Other products that are regulated as ‘drugs’ under the Drugs and Cosmetics Act, such as blood grouping sera, ligatures, sutures, staplers, surgical dressings, umbilical tapes and blood component bags, will also be under the government’s scanner for price control, reports DNA.
“We have already fixed prices of stents; we are further moving towards other medical devices. There has to be uniformity for even smaller items such as catheters and needles,” a senior government official has been quoted as saying.